Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1944 USD | +2.29% |
|
+3.90% | -15.03% |
| 05-16 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
| Market Cap | 315M 275M 253M 238M 445M 29.71B 449M 3.01B 1.17B 14.64B 1.18B 1.16B 50.74B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 411M 358M 330M 311M 581M 38.76B 585M 3.93B 1.53B 19.1B 1.54B 1.51B 66.21B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.3x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.29% | ||
| 1 week | +3.90% | ||
| Current month | -14.17% | ||
| 1 month | -22.24% | ||
| 3 months | -4.05% | ||
| 6 months | -21.64% | ||
| Current year | -15.03% |
| 1 week | 0.18 |  | 0.2 |
| 1 month | 0.18 | | 0.26 |
| Current year | 0.18 | | 0.34 |
| 1 year | 0.18 | | 0.37 |
| 3 years | 0.17 | | 1.09 |
| 5 years | 0.17 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/08/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 09/08/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 08/08/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.29% | +3.90% | -27.89% | -67.11% | 315M | |
| -2.23% | -0.03% | +61.34% | +109.10% | 56.24B | |
| +4.60% | +5.85% | +54.47% | +43.04% | 43.76B | |
| -1.44% | +1.51% | -12.94% | -17.33% | 23.32B | |
| -2.69% | -0.95% | -3.68% | +374.02% | 21.34B | |
| +3.22% | +3.77% | +19.92% | -35.05% | 15.75B | |
| -0.67% | +1.18% | +12.91% | -39.22% | 15.6B | |
| -1.01% | -2.97% | +27.42% | +174.08% | 13.18B | |
| +3.07% | +3.59% | +25.54% | - | 12.01B | |
| +4.95% | +7.51% | +123.21% | +249.05% | 11.87B | |
| Average | +1.01% | +3.33% | +28.03% | +87.84% | 21.34B | |
| Weighted average by Cap. | +0.51% | +3.54% | +37.91% | +97.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 33.92M 31.27M 29.41M 55.03M 3.67B 55.41M 372M 144M 1.81B 146M 143M 6.27B |
| Net income | - | - |
| Net Debt | 96.08M 83.71M 77.17M 72.59M 136M 9.06B 137M 918M 357M 4.46B 361M 353M 15.47B | 125M 109M 100M 94.39M 177M 11.77B 178M 1.19B 464M 5.8B 469M 459M 20.11B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 0.1944 $ | +2.29% | 1,363,871 |
| 17/06/26 | 0.1900 $ | +0.43% | 2,768,029 |
| 16/06/26 | 0.1892 $ | -0.40% | 2,033,892 |
| 15/06/26 | 0.1900 $ | -5.23% | 1,412,437 |
| 12/06/26 | 0.2005 $ | +7.17% | 2,918,579 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1900USD
Average target price
1.000USD
Spread / Average Target
+426.18%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
